Wiskott-Aldrich syndrome: Long-term results of gene therapy developed
A single infusion of genetically corrected autologous hematopoietic stem cells can provide lasting clinical benefits for patients with Wiskott-Aldrich syndrome, a rare genetic disorder that impairs immune and platelet function, exposing affected children from an early age to severe infections, bleeding episodes, eczema and autoimmune complications.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
COVID-19 pandemic drove violence and moral suffering for nurses in Latin America
-
Chronic pain after cesarean delivery linked to poorer quality of life for months and years after giving birth
-
Risk of death rises with rate of overcrowding, corridor care in hospital emergency department
-
New ambulance triage method could reduce emergency visits for chest pain
-
Violence against emergency workers is increasing: Hospital overcrowding a major contributor
-
AI innovation supports screening for 2.2 million US workers exposed to toxic dust
-
Three heart cell receptors share unexpected signal that drives scar formation
-
Malaria parasite can reawaken after years: New vaccine target may block liver infection